DTIL
Precision BioSciences Inc
NASDAQ: DTIL · HEALTHCARE · BIOTECHNOLOGY
$7.15
+3.62% today
Updated 2026-04-30
Market cap
$181.66M
P/E ratio
—
P/S ratio
5.30x
EPS (TTM)
$-3.63
Dividend yield
—
52W range
$4 – $9
Volume
0.3M
Precision BioSciences Inc (DTIL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $92.27M | $-24.17M | $-51.72M | $-73.64M | $-87.39M | $-10.85M | $-45.75M | $-84.11M | $-58.45M | $-65.84M |
| Capital expenditures | $2.08M | $5.57M | $15.68M | $24.67M | $5.03M | $5.80M | $3.32M | $2.28M | $250000.00 | $85000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $419000.00 | $2.45M | $8.94M | $13.79M | $16.51M | $19.20M | $14.04M | $12.60M | $10.19M |
| Free cash flow | $90.20M | $-29.73M | $-67.40M | $-98.30M | $-92.42M | $-16.66M | $-49.07M | $-86.39M | $-58.70M | $-65.93M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $12.43M | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-91.09M | $53.87M | $45.91M | — | — | — |